37
371470.KO MiraeAsset TIGER China Biotech Solactive ETF
- KRW
No recent price
- Total assets
- 39.8B
- Expense ratio
- -
- Dividend yield
- -
- 1-year return
- -18.85%
- Holdings
- 1
- Since
- 2020
Fund data as reported by the issuer, updated Nov 4, 2026. Total assets are in the fund's base currency.
What does 371470.KO invest in?
Tracks Morningstar Gbl Health NR USD- Mostly Non-US stocks (50.3%)
- Largest sector: Healthcare (100.0%)
- Largest region: Asia Emerging (74.6%)
Asset allocation
- Non-US stocks 50.3%
- Other 35.7%
- US stocks 13.3%
- Cash 0.1%
MiraeAsset TIGER China Biotech Solactive ETF performance
Sharpe ratio 0.13- This year
- -11.51%
- 1 year
- -18.85%
- 3 years
- +2.94%
- 5 years
- -7.45%
Volatility 20.2% over 1 year and 28.3% over 3 years. High: expect large swings.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
371470.KO price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
MiraeAsset TIGER China Biotech Solactive ETF top holdings
The holdings of MiraeAsset TIGER China Biotech Solactive ETF are not available yet.
371470.KO sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
371470.KO regional exposure
- Asia Emerging74.6%
- North America20.1%
- Asia Developed4.4%
Share of the stocks in the fund.
Company size
Average market cap 22.4T- Mega cap11.4%
- Big cap27.5%
- Medium cap17.1%
- Small cap5.9%
MiraeAsset TIGER China Biotech Solactive ETF fund profile
- Fund name
- MiraeAsset TIGER China Biotech Solactive ETF
- Ticker
- 371470.KO
- Exchange
- Korea Stock Exchange
- Issuer
- -
- Index tracked
- Morningstar Gbl Health NR USD
- Category
- Healthcare Equity
- Inception date
- Dec 3, 2020
- Trading currency
- KRW
- Expense ratio
- -